[1] |
Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health, 2018, 11(5):605-610. doi: 10.1016/j.jiph.2018.04.005.
doi: 10.1016/j.jiph.2018.04.005
URL
|
[2] |
Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio, 2017, 8(4):e00812-17. doi: 10.1128/mBio.00812-17.
|
[3] |
Alemu A, Tadesse M, Seid G, et al. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia. BMC Infect Dis, 2020, 20(1):87. doi: 10.1186/s12879-020-4817-2.
doi: 10.1186/s12879-020-4817-2
URL
|
[4] |
World Health Organization. Global tuberculosis report 2010. Geneva:World Health Organization, 2010.
|
[5] |
World Health Organization. Global tuberculosis report 2013. Geneva:World Health Organization, 2013.
|
[6] |
Rufai SB, Kumar P, Singh A, et al. Comparison of Xpert MTB/RIF with Line Probe Assay for Detection of Rifampin-Monoresistant Mycobacterium tuberculosis. J Clin Microbiol, 2014, 52(6):1846-1852. doi: 10.1128/JCM.03005-13.
doi: 10.1128/JCM.03005-13
URL
|
[7] |
Uddin MKM, Rahman A, Ather MF, et al. Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh. Infect Drug Resist, 2020, 13:789-797. doi: 10.2147/IDR.S240408.
doi: 10.2147/IDR
URL
|
[8] |
Li M chao, Lu J, Lu Y, et al. rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis. Infect Drug Resist, 2021, 14:4119-4128. doi: 10.2147/IDR.S333433.
doi: 10.2147/IDR.S333433
URL
|
[9] |
Berhanu RH, Schnippel K, Kularatne R, et al. Discordant rifampicin susceptibility results are associated with XpertW MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis, 2019, 23(3):358-362. doi: 10.5588/ijtld.16.0837.
doi: 10.5588/ijtld.16.0837
URL
pmid: 30940300
|
[10] |
Blakemore R, Nabeta P, Davidow AL, et al. A Multisite Assessment of the Quantitative Capabilities of the Xpert MTB/RIF Assay. Am J Respir Crit Care Med, 2011, 184(9):1076-1084. doi: 10.1164/rccm.201103-0536OC.
doi: 10.1164/rccm.201103-0536OC
URL
|
[11] |
Lee HS, Kee SJ, Shin JH, et al. Xpert MTB/RIF Assay as a Substitute for Smear Microscopy in an Intermediate-Burden Setting. Am J Respir Crit Care Med, 2019, 199(6):784-794. doi: 10.1164/rccm.201804-0654OC.
doi: 10.1164/rccm.201804-0654OC
URL
|
[12] |
Jiang J, Yang J, Shi Y, et al. Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis. Infect Dis (Lond), 2020, 52(11):763-775. doi: 10.1080/23744235.2020.1788222.
|
[13] |
Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary Specimens. J Clin Microbiol, 2011, 49(12):4138-4141. doi: 10.1128/JCM.05434-11.
doi: 10.1128/JCM.05434-11
URL
|
[14] |
Ullah I, Shah AA, Basit A, et al. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect Dis, 2016, 16:413. doi: 10.1186/s12879-016-1745-2.
doi: 10.1186/s12879-016-1745-2
URL
|
[15] |
李丽, 孟繁荣, 刘志辉. 中国利福平耐药结核分枝杆菌株rpoB基因耐药决定区基因突变的分子特征. 实用医学杂志, 2015, 31(14):2372-2375. doi: 10.3969/j.issn.1006-5725.2015.14.042.
|
[16] |
Jamieson FB, Guthrie JL, Neemuchwala A, et al. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis. J Clin Microbiol, 2014, 52(6):2157-2162. doi: 10.1128/JCM.00691-14.
doi: 10.1128/JCM.00691-14
URL
pmid: 24740074
|
[17] |
Bahrmand AR, Titov LP, Tasbiti AH, et al. High-Level Rifampin Resistance Correlates with Multiple Mutations in the rpoB Gene of Pulmonary Tuberculosis Isolates from the Afghanistan Border of Iran. J Clin Microbiol, 2009, 47(9):2744-2750. doi: 10.1128/JCM.r00548-09.
doi: 10.1128/JCM.r00548-09
URL
pmid: 19721079
|
[18] |
胡族琼, 刘燕文, 周文, 等. 结核分枝杆菌rpoB基因突变特征与利福平耐药水平关系的研究. 中国人兽共患病学报, 2016, 32(1):39-44,50. doi: 10.3969/j.issn.1002-2694.2016.01.009.
|